| # | Drug | Count |
|---|---|---|
| 0 | OXALIPLATIN | 24 |
| 1 | CAPECITABINE | 13 |
| 2 | FLUOROURACIL | 10 |
| 3 | FLUOROURACIL CREAM, 0.5% | 10 |
| 4 | RIFAXIMIN | 9 |
| 5 | LACTULOSE | 8 |
| 6 | SPIRONOLACTONE | 8 |
| 7 | FUROSEMIDE | 6 |
| 8 | LETROZOLE | 5 |
| 9 | LETROZOLE TABLETS | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ETHIODIZED OIL | 2 | 0.0015 |
| 1 | PURIXAN | 1 | 0.0013 |
| 2 | EDARAVONE | 1 | 0.0006 |
| 3 | DAPRODUSTAT | 1 | 0.0005 |
| 4 | RIFAXIMIN | 9 | 0.0004 |
| 5 | ETHOSUXIMIDE | 1 | 0.0004 |
| 6 | NADOLOL | 3 | 0.0004 |
| 7 | RUFINAMIDE | 1 | 0.0004 |
| 8 | OXALIPLATIN | 24 | 0.0003 |
| 9 | EPIRUBICIN HYDROCHLORIDE | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 1 | Rifamycin Antibacterial [EPC] | 9 | 0.0002 |
| 2 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 3 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 4 | Platinum-based Drug [EPC] | 25 | 0.0001 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 22 | 0.0001 |
| 6 | Radiographic Contrast Agent [EPC] | 2 | 0.0001 |
| 7 | Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] | 4 | 0.0001 |
| 8 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |